CUAMC
MRNA icon

China Universal Asset Management Company’s Moderna MRNA Stock Holding History

China Universal Asset Management Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Sell
63,149
-6,936
-10% -$359K 0.26% 67
2026
Q1 		$3.56M Buy
70,085
+6,424
+10% +$300K 0.27% 68
2025
Q4 		$1.88M Sell
63,661
-4,539
-7% -$123K 0.14% 118
2025
Q3 		$1.76M Sell
68,200
-9,476
-12% -$264K 0.15% 124
2025
Q2 		$2.14M Sell
77,676
-515
-0.7% -$13.6K 0.2% 101
2025
Q1 		$2.22M Sell
78,191
-4,208
-5% -$149K 0.21% 97
2024
Q4 		$3.43M Buy
82,399
+2,788
+4% +$133K 0.32% 65
2024
Q3 		$5.32M Buy
79,611
+32,118
+68% +$2.95M 0.59% 38
2024
Q2 		$5.64M Sell
47,493
-28,464
-37% -$3.6M 0.8% 37
2024
Q1 		$8.09M Buy
75,957
+30,302
+66% +$3.05M 1.03% 25
2023
Q4 		$4.54M Buy
45,655
+33,665
+281% +$2.83M 0.88% 30
2023
Q3 		$1.24M Buy
11,990
+5,767
+93% +$643K 0.36% 70
2023
Q2 		$756K Buy
6,223
+68
+1% +$9.07K 0.23% 93
2023
Q1 		$945K Sell
6,155
-3,334
-35% -$550K 0.32% 74
2022
Q4 		$1.7M Buy
9,489
+4,666
+97% +$763K 0.69% 53
2022
Q3 		$570K Sell
4,823
-7,138
-60% -$1.08M 0.24% 74
2022
Q2 		$1.71M Buy
11,961
+10,995
+1,138% +$1.57M 0.72% 53
2022
Q1 		$166K Hold
966
– – 0.06% 71
2021
Q4 		$245K Buy
+966
New +$282K 0.06% 77

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

China Universal Asset Management Company's MRNA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Moderna (MRNA) stake by 9.9% in Q2 2026, selling an estimated $359K and leaving 63,149 shares worth $4.42M. The position accounts for 0.26% of the portfolio, ranked #67.

China Universal Asset Management Company first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.09M in Q1 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • China Universal Asset Management Company held 63,149 shares of Moderna worth $4.42M as of Q2 2026.
  • China Universal Asset Management Company sold 6,936 Moderna shares in Q2 2026, an estimated $359K.
  • Moderna made up 0.26% of China Universal Asset Management Company's portfolio in Q2 2026, its #67 holding.
  • China Universal Asset Management Company first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • China Universal Asset Management Company's Moderna position peaked at $8.09M in Q1 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.